The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...

Henry Gosebruch is now chief executive of the spinout, which has roughly $2.5 billion and plans to use dealmaking to build a ...

The law in particular will affect CVS and UnitedHealth, both of which operate physical pharmacies in the state along with ...

The data could help the Enhertu regimen overtake a drug combination that’s been used as the initial treatment for ...

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

The company’s board reiterated its recommendation to instead pursue an offer from SK Capital and Carlyle that’s worth about ...

The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...

The leaked budget draft, if approved by Congress, would reduce the FDA’s budget authority, indicating more disruption could ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...